139 related articles for article (PubMed ID: 10608412)
1. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium.
de Haën C; Cabrini M; Akhnana L; Ratti D; Calabi L; Gozzini L
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S161-8. PubMed ID: 10608412
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tissue distribution in animals of gadobenate ion, the magnetic resonance imaging contrast enhancing component of gadobenate dimeglumine 0.5 M solution for injection (MultiHance).
Lorusso V; Arbughi T; Tirone P; de Haën C
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S181-94. PubMed ID: 10608414
[TBL] [Abstract][Full Text] [Related]
3. Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations.
Johansson L; Kirchin MA; Ahlström H
Acta Radiol; 2012 Dec; 53(10):1112-7. PubMed ID: 23081961
[TBL] [Abstract][Full Text] [Related]
4. Nebulized liposomal gadobenate dimeglumine contrast formulation for magnetic resonance imaging of larynx and trachea.
Wei X; Wu H; Lu Q; Xu J; Xu Y
Int J Nanomedicine; 2011; 6():3383-91. PubMed ID: 22267923
[TBL] [Abstract][Full Text] [Related]
5. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
Knopp MV; Runge VM; Essig M; Hartman M; Jansen O; Kirchin MA; Moeller A; Seeberg AH; Lodemann KP
Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Low-Dose Higher-Relaxivity and Standard-Dose Lower-Relaxivity Contrast Media for Delayed-Enhancement MRI: A Blinded Randomized Crossover Study.
Cheong BY; Duran C; Preventza OA; Muthupillai R
AJR Am J Roentgenol; 2015 Sep; 205(3):533-9. PubMed ID: 26295638
[TBL] [Abstract][Full Text] [Related]
7. Toxicological safety evaluation of gadobenate dimeglumine 0.5 M solution for injection (MultiHance), a new magnetic resonance imaging contrast medium.
Morisetti A; Bussi S; Tirone P; de Haën C
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S207-17. PubMed ID: 10608416
[TBL] [Abstract][Full Text] [Related]
8. Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.
Rudolph A; von Knobelsdorff-Brenkenhoff F; Wassmuth R; Prothmann M; Utz W; Schulz-Menger J
J Magn Reson Imaging; 2014 May; 39(5):1153-60. PubMed ID: 24151119
[TBL] [Abstract][Full Text] [Related]
9. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
10. A clinical comparison of the safety and efficacy of MultiHance (gadobenate dimeglumine) and Omniscan (Gadodiamide) in magnetic resonance imaging in patients with central nervous system pathology.
Runge VM; Armstrong MR; Barr RG; Berger BL; Czervionke LF; Gonzalez CF; Halford HH; Kanal E; Kuhn MJ; Levin JM; Low RN; Tanenbaum LN; Wang AM; Wong W; Yuh WT; Zoarski GH
Invest Radiol; 2001 Feb; 36(2):65-71. PubMed ID: 11224753
[TBL] [Abstract][Full Text] [Related]
11. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine.
Pediconi F; Catalano C; Occhiato R; Venditti F; Fraioli F; Napoli A; Kirchin MA; Passariello R
Radiology; 2005 Oct; 237(1):45-56. PubMed ID: 16126926
[TBL] [Abstract][Full Text] [Related]
12. Contrast visibility for indirect MR arthrography with different protein contents and agent relaxivities at different field strengths: an in vitro model.
Nouh MR; Schweitzer ME; Ragatte RR
Eur J Radiol; 2011 Nov; 80(2):559-64. PubMed ID: 21242041
[TBL] [Abstract][Full Text] [Related]
13. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine.
Knopp MV; Bourne MW; Sardanelli F; Wasser MN; Bonomo L; Boetes C; Müller-Schimpfle M; Hall-Craggs MA; Hamm B; Orlacchio A; Bartolozzi C; Kessler M; Fischer U; Schneider G; Oudkerk M; Teh WL; Gehl HB; Salerio I; Pirovano G; La Noce A; Kirchin MA; Spinazzi A
AJR Am J Roentgenol; 2003 Sep; 181(3):663-76. PubMed ID: 12933457
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.
Pediconi F; Catalano C; Padula S; Roselli A; Dominelli V; Cagioli S; Kirchin MA; Pirovano G; Passariello R
AJR Am J Roentgenol; 2008 Nov; 191(5):1339-46. PubMed ID: 18941066
[TBL] [Abstract][Full Text] [Related]
15. Effects of gadolinium-based magnetic resonance imaging contrast media on red blood cells and K562 cancer cells.
Supawat B; Moungthong P; Chanloi C; Jindachai N; Tima S; Kothan S; Udomtanakunchai C; Tungjai M
J Trace Elem Med Biol; 2020 Dec; 62():126640. PubMed ID: 32932175
[TBL] [Abstract][Full Text] [Related]
16. Effect of abrupt substitution of gadobenate dimeglumine for gadopentetate dimeglumine on rate of allergic-like reactions.
Davenport MS; Dillman JR; Cohan RH; Hussain HK; Khalatbari S; McHugh JB; Ellis JH
Radiology; 2013 Mar; 266(3):773-82. PubMed ID: 23238152
[TBL] [Abstract][Full Text] [Related]
17. Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration.
Weberling LD; Kieslich PJ; Kickingereder P; Wick W; Bendszus M; Schlemmer HP; Radbruch A
Invest Radiol; 2015 Nov; 50(11):743-8. PubMed ID: 26352749
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents.
Laurent S; Elst LV; Muller RN
Contrast Media Mol Imaging; 2006; 1(3):128-37. PubMed ID: 17193689
[TBL] [Abstract][Full Text] [Related]
19. Breast MRI using a high-relaxivity contrast agent: an overview.
Carbonaro LA; Pediconi F; Verardi N; Trimboli RM; Calabrese M; Sardanelli F
AJR Am J Roentgenol; 2011 Apr; 196(4):942-55. PubMed ID: 21427349
[TBL] [Abstract][Full Text] [Related]
20. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla.
Pintaske J; Martirosian P; Graf H; Erb G; Lodemann KP; Claussen CD; Schick F
Invest Radiol; 2006 Mar; 41(3):213-21. PubMed ID: 16481903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
